SUDARSHAN PHARMA INDUSTRIES
Back to Balance Sheet
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹260 Cr | ₹160 Cr | ₹118 Cr | ₹103 Cr | ₹71 Cr |
What is the latest Total Current Liabilities ratio of SUDARSHAN PHARMA INDUSTRIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹260 Cr |
| Mar2024 | ₹160 Cr |
| Mar2023 | ₹118 Cr |
| Mar2022 | ₹103 Cr |
| Mar2021 | ₹71 Cr |
How is Total Current Liabilities of SUDARSHAN PHARMA INDUSTRIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹260 Cr | 61.81 | |
| Mar2024 | ₹160 Cr | 35.46 | |
| Mar2023 | ₹118 Cr | 15.45 | |
| Mar2022 | ₹103 Cr | 44.09 | |
| Mar2021 | ₹71 Cr | - | |
Compare Total Current Liabilities of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹1,016.5 Cr | 1.3% | 4% | 31% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | 1.8% | -1.7% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 2.6% | 9.8% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | 2.4% | -0.5% | 36% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 1.8% | -3.7% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 4.5% | 1.8% | -10% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | 1.3% |
4% |
31% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses